12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The current study is designed to test the long-term (12-month) safety and efficacy of
LCP-AtorFen, a combination of atorvastatin and fenofibrate, in patients with dyslipidemia